Vanda Pharmaceuticals | VNDA - Eps Gewinn Pro Aktie

Aktienkurs
7.21
Täglich Wechseln
0.39 5.72%
Monatlich
-16.16%
Jährlich
51.15%
Q1 Prognose
6.91

Fiscal Kalender Aktuell Konsens Zuletzt Datum




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Akebia Therapeutics USD -0.04 0.04 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -1.54 0.21 2025-12
J&J USD 2.46 0.34 2025-12
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
Merck USD 2.04 0.54 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Moderna USD -2.11 1.6 2025-12
Novartis USD 1.54 0.48 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.53 1.38 2025-12
Takeda JPY 65.74 73.57 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12
Veracyte USD 0.53 0.02 2025-12